Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events - No Study Results Posted

Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events (CAPPA)

This study is ongoing, but not recruiting participants.

Study NCT00886574 Information provided by Hanyang University

First Received: April 22, 2009 Last Updated: June 3, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	February 2014
Estimated Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)